Acute and chronic leptin reduces food intake and body weight in goldfish (Carassius auratus).
The purpose of the present study was to elucidate the possible role of leptin in food intake and body weight regulation in goldfish. We examined the effects of i.c.v. or i.p. acute leptin administration on food intake in food-deprived goldfish at different time intervals post-injection (0-2, 2-8 and 0-8 h). Food intake was reduced by i.p. administered leptin (1 microg) at 8 h post-injection, without statistically significant differences after i.c.v. treatment. The present study shows for the first time in a teleost that chronic (10 days) leptin treatment (i.p.) reduces food intake, body weight gain, specific growth rate and food efficiency ratio. Moreover, lipid and carbohydrate metabolism seems to be regulated by leptin in fish. Chronic leptin treatment increased lipid mobilization and carbohydrate storage as hepatic and muscle glycogen. Finally, leptin could mediate its actions on energy homeostasis in fish, at least in part, through interactions with hypothalamic catecholamines, since chronic leptin treatment reduced both hypothalamic noradrenergic and dopaminergic turnover without significant modifications in hypothalamic serotoninergic and neuropeptide Y (NPY) systems. In summary, our results suggest that leptin can regulate feeding behaviour and body weight homeostasis in fish.
de Pedro
N
N
Departamento Fisiología (Fisiología Animal II), Facultad de Biología, Universidad Complutense de Madrid, 28040 Madrid, Spain. ndepedro@bio.ucm.es
Martínez-Alvarez
R
R
Delgado
M J
MJ
D000818:Animals; D001835:Body Weight / Q000187:drug effects*; D050260:Carbohydrate Metabolism / Q000187:drug effects; D002395:Catecholamines / Q000378:metabolism; D004435:Eating / Q000187:drug effects*; D004734:Energy Metabolism / Q000187:drug effects; D006003:Glycogen / Q000378:metabolism; D006054:Goldfish / Q000254:growth & development / Q000378:metabolism*; D007031:Hypothalamus / Q000187:drug effects / Q000378:metabolism; D007274:Injections, Intraperitoneal; D007275:Injections, Intravenous; D020738:Leptin / Q000494:pharmacology*; D050356:Lipid Metabolism / Q000187:drug effects; D008099:Liver / Q000378:metabolism; D009132:Muscles / Q000378:metabolism; D009478:Neuropeptide Y / Q000378:metabolism; D012701:Serotonin / Q000378:metabolism; D013217:Starvation; D013997:Time Factors
D002395:Catecholamines; D020738:Leptin; D009478:Neuropeptide Y; D012701:Serotonin; D006003:Glycogen